Frontlight ResearchEarly access
Taking people in United StatesNo phase
Parathyroid Tumor Clonal Status
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 839 people, planned
- Started
- 28 Jul 2023
- Expected to end
- 31 Jan 2032
- Type of study
- Observational
- Record updated
- 12 May 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 1. Diagnosed with hyperparathyroidism (primary, secondary, or tertiary), biochemically confirmed (e.g., serum calcium and/or intact PTH consistent with the underlying etiology), and undergoing clinically indicated management
- Female and male patients
- Age ≥ 18 years
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable)
Who cannot take part
- Patients currently taking lithium or with a history of lithium use
- Patients with a history of cervicofacial irradiation
- Pregnant patients
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- Washington University School of MedicineSt Louis, United StatesContact: Bryan BearTaking people
About the trial
What the trial wants to find out
To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Phase 2 Biomarker Study of Parathyroid Tumor Clonal Status in Hyperparathyroid Disorders (Primary, Secondary, and Tertiary)
- Fit questions
- Built from NCT05997810, who can take part
- Record updated
- 12 May 2026